Epigenetic Modulation in Disease: Mechanisms, Biomarkers, and Therapeutic Strategies
Sr No:
Page No:
1-5
Language:
English
Authors:
Yasir Haider Al-Mawlah*, Hussein Fadil Ibrahim
Received:
2025-11-19
Accepted:
2025-12-26
Published Date:
2026-01-03
Abstract:
Epigenetic regulation involves heritable changes in gene expression that do not alter
the underlying DNA sequence. The importance of epigenetics in the pathogenesis of various
diseases has become increasingly apparent, as it regulates crucial processes such as cell
differentiation, proliferation, and apoptosis. This systematic review aims to comprehensively
explore the mechanisms of epigenetic regulation, its role in disease, emerging biomarkers for
disease detection, and potential therapeutic strategies targeting epigenetic alterations.
Mechanisms like DNA methylation, histone modifications, non-coding RNA regulation, and
chromatin remodeling contribute to the onset and progression of cancers, cardiovascular
diseases, neurodegenerative disorders, and metabolic conditions. Recent advances in epigenetic
therapies, such as DNA methylation inhibitors, histone deacetylase inhibitors, and gene editing
technologies, hold great promise for therapeutic intervention. This review discusses these
developments in detail and explores how epigenetic therapies can be integrated into personalized
medicine.
Keywords:
Zingiber officinale, albumin-induced, inflammation, interleukin, and tumor necrosis factor.